Beckley Waves

Daniel Love, Co-founder and Partner, leads investment strategy, new partnerships, and business incubation. Love brings experience from Julian Robertson's family foundation and venture-backed startups. Rock Feilding-Mellen, also a Co-founder and Partner, works on investor relations, network cultivation, and regulatory issues. No formal investment committee structure is disclosed.

The firm describes itself as a holding company, acquiring and incubating operating businesses rather than making venture fund commitments. Its portfolio companies will deliver psychedelic-assisted therapies, not develop the drugs themselves. No launch of a venture fund or separate investment vehicle has been publicly announced.

No. Beckley Waves focuses exclusively on care delivery infrastructure — clinics, training, and digital health. Amanda Feilding's separate entity Beckley Psytech handles drug development, while the Beckley Foundation runs policy research. These entities are not subsidiaries of Beckley Waves.

Amanda Feilding founded all three. The Beckley Foundation is a non-profit research and policy institute. Beckley Psytech is a biopharmaceutical company developing psychedelic compounds. Beckley Waves is a for-profit holding company for care delivery businesses. They operate independently under distinct governance structures, with Feilding serving as the common founder.

The firm does not publicly specify its co-investment policy. Given its holding-company structure and permanent-capital orientation, deals are typically structured as direct acquisitions or strategic partnerships rather than limited-partner commitments to external funds.

The source of the firm's capital has not been publicly disclosed. No named external limited partners, family office backers, or fund structures have been revealed in available company materials (per Altss research). Daniel Love's background includes work at a $1B+ foundation, but no direct link to Beckley Waves' capitalization has been confirmed.

The firm is headquartered in Oxford, United Kingdom, and maintains an active focus on the United States. Its policy research and editorial arm tracks regulatory developments in Australia and the European Union, suggesting potential future operating markets when local frameworks permit.